D012565Activities & BehaviorsF04.824291290.938037Schizophrenic Psychologyprns:emailEncryptedemail addressprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentvivo:hrJobTitleHR job titleInformation Resourcevivo:linkAnchorTextlink anchor textPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forURLLinkvivo:webpagewebpagerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson28648819RodrÃguez G, Neugebauer NM, Yao KL, Meltzer HY, Csernansky JG, Dong HPharmacology, biochemistry, and behavior?9-tetrahydrocannabinol (?9-THC) administration after neonatal exposure to phencyclidine potentiates schizophrenia-related behavioral phenotypes in mice. Pharmacol Biochem Behav. 2017 08; 159:6-11.Pharmacol Biochem Behav2017-06-23T00:00:002017?9-tetrahydrocannabinol (?9-THC) administration after neonatal exposure to phencyclidine potentiates schizophrenia-related behavioral phenotypes in mice.JeanDecety02dqDrUMOfnamXNnYUHhvWD+6g==Jean Decety41.7886000000000087.598699999999993501Decety, JeanProfessor28750582Davidson M, Saoud J, Staner C, Noel N, Luthringer E, Werner S, Reilly J, Schaffhauser JY, Rabinowitz J, Weiser M, Luthringer RThe American journal of psychiatryEfficacy and Safety of MIN-101: A 12-Week Randomized, Double-Blind, Placebo-Controlled Trial of a New Drug in Development for the Treatment of Negative Symptoms in Schizophrenia. Am J Psychiatry. 2017 12 01; 174(12):1195-1202.Am J Psychiatry2017-07-28T00:00:002017Efficacy and Safety of MIN-101: A 12-Week Randomized, Double-Blind, Placebo-Controlled Trial of a New Drug in Development for the Treatment of Negative Symptoms in Schizophrenia.29643358Shafee R, Nanda P, Padmanabhan JL, Tandon N, Alliey-Rodriguez N, Kalapurakkel S, Weiner DJ, Gur RE, Keefe RSE, Hill SK, Bishop JR, Clementz BA, Tamminga CA, Gershon ES, Pearlson GD, Keshavan MS, Sweeney JA, McCarroll SA, Robinson EBTranslational psychiatryPolygenic risk for schizophrenia and measured domains of cognition in individuals with psychosis and controls. Transl Psychiatry. 2018 04 12; 8(1):78.Transl Psychiatry2018-04-12T00:00:002018Polygenic risk for schizophrenia and measured domains of cognition in individuals with psychosis and controls.31375316Rabinowitz J, Badescu S, Palamarchuk P, Filyk V, Voloshchuk A, Rud V, Melnyk E, Skrypnikov A, Davidson M, Saoud J, Luthringer RSchizophrenia researchPersonal and social adjustment effects of roluperidone in patients with schizophrenia and negative symptoms: Results from an exploratory outcome of a randomized placebo-controlled trial. Schizophr Res. 2019 09; 211:103-104.Schizophr Res2019-07-30T00:00:002019Personal and social adjustment effects of roluperidone in patients with schizophrenia and negative symptoms: Results from an exploratory outcome of a randomized placebo-controlled trial.MollyErickson2md7AqIeCuPXwFpxY07n8GT98IW47aA=Molly Erickson41.7886000000000087.598699999999993869Erickson, MollyAssistant Professor5.45060.018690329research area of0.8612660.00755085138subject area forPsychiatry and Behavioral Neuroscience-Adult PsychiatryPsychiatry and Behavioral Neuroscience-Research34851373Bansal S, Bae GY, Robinson BM, Hahn B, Waltz J, Erickson M, Leptourgos P, Corlett P, Luck SJ, Gold JMJAMA psychiatryAssociation Between Failures in Perceptual Updating and the Severity of Psychosis in Schizophrenia. JAMA Psychiatry. 2022 02 01; 79(2):169-177.JAMA Psychiatry2022-02-01T00:00:002022Association Between Failures in Perceptual Updating and the Severity of Psychosis in Schizophrenia.https://psychiatry.uchicago.edu/faculty/sarah-k-keedy-phdPsychiatry & Behavioral Neuroscience Dept pagehttp://ericksonmapslab.uchicago.edu/Memory and Perception in Schizophrenia Labhttp://voices.uchicago.edu/censl/Cognition Emotion Neuroscience LabUniversity of ChicagoElliotGershonElliot S. Gershon41.78927490000000-87.601250000000002268Gershon, ElliotPROFESSORSarah K.KeedyxGlsDqUMOe7KlTRxY07n8GT98IW47aA=Sarah K. Keedy41.78927490000000-87.601250000000002467Keedy, Sarah K.Associate ProfessorMichael H.DavidsonMichael H. Davidson41.78927490000000-87.60125000000000611Davidson, Michael H.Clinical Professortrue1Clinical ProfessorClinical Professortrue1PROFESSORPROFESSORtrue1Associate ProfessorAssociate Professortrue1Assistant ProfessorAssistant Professortrue1ProfessorProfessorMedicine-CardiologyPsychiatry & Behav. NeurosciPsychology